Each subtype (gastric, intestinal, pancreatobiliary or oncocytic type) of pancreatic IPMNs appears to have GNAS and/or K-ras mutations at similar frequency [5]. Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.